Originally Posted by
ptarmigan
As contrasted against:
We end up with no gains at all. In the meantime, the company has opened Paris and Hong Kong anyway, under current FDA. No problem getting Captains to bid, as there are no raises anyway. The new hires jump at the chance and all seats are easily filled.
In the alternative you seem to favor, we have gained what, exactly?
I keep hearing this argument and it really doesn't hold any water...Yes it is true the Captains will hold it no problem, but the FO seat will go wicked junior, and the company doesn't want that at all...Remember when we had the excess bid? It was more of a seniority realignment bid, the company could not furlough because without that bid, ANC would have been gutted and a ghost town, and so would HKG...The company doesn't want Junior guys/New Hires in an FDA because furloughing becomes a real problem for them...And you really think a new hire can afford to live overseas on the current LOA at 50 bucks an hour?? Fail... As long as 4a2b is not fixed, entry and exit, I am voting NO!
If this thing fails, which in all honesty I think it will pass...that doesn't mean it's shot down completely, we kick it back and make the company fix some things. I guess we will see how important the FDA's are to them...